Preparation and therapeutic evaluation of rutin-phospholipid complex for antidiabetic activity

Journal of Applied Pharmaceutical Science

Volumn 6, Issue 1, 2016, Pages 090-101

  Vankudri, Rashmi ^a   Habbu, Prasanna ^b   Hiremath, Mahesh ^b   Patil, B S ^b   Savant, Chetan ^b  

^a PRIST UNIVERSITY   (India)

^b S E T S COLLEGE OF PHARMACY   (India)

Author keywords

Antidiabetic activity; Bioavailability; OGTT; Rutin phosoholipid complex

Indexed keywords

EID: 84957684955     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2016.600116     Document Type: Article

References (21)

1. Chi Yu Yang, Su Lan Hsiu, Kuo-Ching Wen, et al. Bioavailability and metabollic pharmacokinetics of Rutin and Quercetin in Rats. J of food and drug analysis, 2005; 13(3): 244-250.
2. Friedewald WT, Levy RI, Fredrickson DS. Estimation of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem, 1972; 18: 499.
3. Galigher AE, Kozloff EN. 1971. In: Essentials of practical microtechnique, 2nd edn. Lea and Febiger, Philadelphia, p. 77-79.
4. Goutam B. 2011. Bio-flavonoids with promising antidiabetic potentials: A critical survey. Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry; p.187-212.
5. Guariguata L, Whiting IDR, Hambleton J, et al. Global estimates of diabetes prevalance for 2013 and projections for 2035. Diabetes research and clinical practice, 2014; 103(2): 137-149.
6. Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev, 2009; 14(3): 226-46.
7. Kumar GPS, Arulselwan P, Kumar DS, et al. Anti-Diabetic activity of Fruits of Terminalia chebula on Streptozotocin Induced Diabetic Rats. J Health Sci, 2006; 52(3): 283-91.
8. Liu X, Dong M, Chen X, et al. Antioxidant activity and phenolics of an endophytic Xylaria sp. from Ginkgo biloba. Food Chem, 2005; 105: 548-54.
9. Maiti K, Mukherjee K, Gantait A, et al. Curcumin-phospholipid complex: therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm, 2007; 330 (1-2): 55-163.
10. Matti R, Das UK, Ghosh D. Attenuation of hyperglycemia and hyperlipidemia in streptozotocin induced diabetic rats by aqueous extract of seed of Tamarindus indica. Biol. Pharm. Bull, 2005; 28:1172-1176.
11. Mukherjee PK. 2003. Plant products with hypercholesterolemic potentials. In:Taylor, S.L.(Ed), Advances in food and Nutrition Research. Elsevier Academic Press, New York, p. 277-338.
12. Muruganandan S, Srinivasan K, Gupta S, et al. Effect of mangiferin on hyperglycemia and atherogenicity in Streptozotocin-diabetic rats. J Ethnopharmacol, 2005; 97(3): 497-501.
13. Prasanna H, Ramesh K, Rashmi V. Preparation and evaluation of Bocopa-Phospholipid complex for antiamnesic activity. Drug invention today, 2013; 5:13-21.
14. Rajkumar M, Uttam KD, Debidas G. Attenuation of hyperglycemia and hyperlipedmia in streptozotocin induced diabetic rats by aqueous extract of seed of Tamarandus indica. Biol pharm bull, 2005; 28:1172-1176.
15. Robertson RP. Estimation of ß-cell mass by metabolic tests: necessary, but how sufficient? Diabetes, 2007; 56: 2420-24.
16. Shirwaikar A, Rajendran K. Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J Ethnopharmacol, 2006; 112: 1-6.
17. Singleton JR, Smith AG, Russell JW, et al. Microvascular complications of impaired glucose tolerance. Diabetes, 2003; 52: 2867-73.
18. Thurapati P. R., Mettu, S. R. Phytosomes: a novel phyto-phospholipid carrier for herbaldrug delivery. Int Res J Pharm, 2011; 2(6): 28-33.
19. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care, 1999; 22: 920-24.
20. Upendra Rao M, Sreenivasulu M, Chengaiah B, et al. Herbal Medicines for Diabetes Mellitus: A Review. Int J Pharm Tech Res, 2010; 2(3):1883-92.
21. Yanyu X, Yunmei S, Zhipeng C, et al. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 2006; 307(1): 77-82.